NASDAQ:FPRX - Five Prime Therapeutics News Headlines

$5.68
+0.09 (+1.61 %)
(As of 07/16/2019 10:12 AM ET)
Today's Range
$5.53
Now: $5.6850
$5.69
50-Day Range
$5.59
MA: $6.49
$9.05
52-Week Range
$5.55
Now: $5.6850
$17.80
Volume55,241 shs
Average Volume669,436 shs
Market Capitalization$205.00 million
P/E RatioN/A
Dividend YieldN/A
Beta2.67

Headlines

Five Prime Therapeutics (NASDAQ FPRX) News Headlines

Source:
DateHeadline
Five Prime Therapeutics Inc (NASDAQ:FPRX) Given Average Recommendation of "Hold" by BrokeragesFive Prime Therapeutics Inc (NASDAQ:FPRX) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - July 12 at 4:31 PM
$5.53 Million in Sales Expected for Five Prime Therapeutics Inc (NASDAQ:FPRX) This Quarter$5.53 Million in Sales Expected for Five Prime Therapeutics Inc (NASDAQ:FPRX) This Quarter
www.americanbankingnews.com - July 2 at 4:44 AM
-$0.86 Earnings Per Share Expected for Five Prime Therapeutics Inc (NASDAQ:FPRX) This Quarter-$0.86 Earnings Per Share Expected for Five Prime Therapeutics Inc (NASDAQ:FPRX) This Quarter
www.americanbankingnews.com - June 30 at 6:11 AM
Estimating The Fair Value Of Five Prime Therapeutics, Inc. (NASDAQ:FPRX)Estimating The Fair Value Of Five Prime Therapeutics, Inc. (NASDAQ:FPRX)
finance.yahoo.com - June 25 at 6:58 PM
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy?Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy?
finance.yahoo.com - June 24 at 4:31 PM
Five Prime Therapeutics Appoints Lori Lyons-Williams to its Board of DirectorsFive Prime Therapeutics Appoints Lori Lyons-Williams to its Board of Directors
finance.yahoo.com - June 24 at 4:31 PM
Five Prime Therapeutics (FPRX) Looks Good: Stock Adds 9.2% in SessionFive Prime Therapeutics (FPRX) Looks Good: Stock Adds 9.2% in Session
finance.yahoo.com - June 18 at 3:50 PM
Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of DirectorsFive Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors
www.businesswire.com - June 9 at 3:24 PM
Five Prime Therapeutics Presents Monotherapy Data From the Phase 1a/1b Trial of FPA150 in Patients With Advanced Solid Tumors at the 2019 ASCO Annual MeetingFive Prime Therapeutics Presents Monotherapy Data From the Phase 1a/1b Trial of FPA150 in Patients With Advanced Solid Tumors at the 2019 ASCO Annual Meeting
www.businesswire.com - June 1 at 11:02 AM
Five Prime Therapeutics to Present at Two Upcoming Healthcare ConferencesFive Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
finance.yahoo.com - May 24 at 6:35 PM
Five Prime Therapeutics Appoints Carol Schafer to its Board of DirectorsFive Prime Therapeutics Appoints Carol Schafer to its Board of Directors
www.businesswire.com - May 15 at 7:46 PM
Five Prime Therapeutics (FPRX) Q1 2019 Earnings Call TranscriptFive Prime Therapeutics (FPRX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 9 at 7:17 PM
Edited Transcript of FPRX earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of FPRX earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 7:17 PM
Five Prime Therapeutics (FPRX) Reports Q1 Loss, Misses Revenue EstimatesFive Prime Therapeutics (FPRX) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 9 at 8:51 AM
Earnings Preview: Five Prime Therapeutics (FPRX) Q1 Earnings Expected to DeclineEarnings Preview: Five Prime Therapeutics (FPRX) Q1 Earnings Expected to Decline
finance.yahoo.com - May 1 at 7:06 PM
What Should You Know About Five Prime Therapeutics, Inc.'s (NASDAQ:FPRX) Earnings Trajectory?What Should You Know About Five Prime Therapeutics, Inc.'s (NASDAQ:FPRX) Earnings Trajectory?
finance.yahoo.com - April 18 at 8:53 AM
Five Prime Therapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on May 8Five Prime Therapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on May 8
finance.yahoo.com - April 18 at 8:53 AM
Will Five Prime Therapeutics Continue to Surge Higher?Will Five Prime Therapeutics Continue to Surge Higher?
finance.yahoo.com - March 19 at 7:11 PM
Five Prime Has 5 Drugs in its PipelineFive Prime Has 5 Drugs in its Pipeline
finance.yahoo.com - March 11 at 11:14 AM
Five Prime Therapeutics to Present at Cowen and Company 39th Annual Health Care ConferenceFive Prime Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 5 at 6:27 PM
Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q4 2018 Results - Earnings Call TranscriptFive Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 8:50 AM
Edited Transcript of FPRX earnings conference call or presentation 26-Feb-19 9:30pm GMTEdited Transcript of FPRX earnings conference call or presentation 26-Feb-19 9:30pm GMT
finance.yahoo.com - February 27 at 8:50 AM
Five Prime Therapeutics Inc (FPRX) Q4 2018 Earnings Conference Call TranscriptFive Prime Therapeutics Inc (FPRX) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 26 at 11:32 PM
Five Prime Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsFive Prime Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - February 26 at 6:18 PM
Five Prime Therapeutics Doses First Patient in Phase 1b Trial of FPA150Five Prime Therapeutics Doses First Patient in Phase 1b Trial of FPA150
finance.yahoo.com - February 21 at 9:12 AM
Form SC 13G/A FIVE PRIME THERAPEUTICS Filed by: STATE STREET CORP - StreetInsider.comForm SC 13G/A FIVE PRIME THERAPEUTICS Filed by: STATE STREET CORP - StreetInsider.com
www.streetinsider.com - February 15 at 8:59 AM
Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26 - Business WireFive Prime Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26 - Business Wire
www.businesswire.com - February 7 at 6:18 PM
Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26
finance.yahoo.com - February 7 at 6:18 PM
Five Prime Therapeutics to Present at the Guggenheim Healthcare Talks Idea ForumFive Prime Therapeutics to Present at the Guggenheim Healthcare Talks Idea Forum
finance.yahoo.com - February 5 at 10:57 AM
Five Prime Therapeutics, Inc. (FPRX) Shares March Higher, Can It Continue?Five Prime Therapeutics, Inc. (FPRX) Shares March Higher, Can It Continue?
finance.yahoo.com - January 24 at 8:51 AM
Five Primes bemarituzumab shows positive action in early-stage gastric cancer study; shares up 7%Five Prime's bemarituzumab shows positive action in early-stage gastric cancer study; shares up 7%
seekingalpha.com - January 17 at 6:50 PM
Five Prime Therapeutics Inc.Five Prime Therapeutics Inc.
www.barrons.com - January 17 at 6:50 PM
Five Prime Therapeutics Presents Data from Safety Lead-in to Phase 3 FIGHT Trial of Bemarituzumab at 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers SymposiumFive Prime Therapeutics Presents Data from Safety Lead-in to Phase 3 FIGHT Trial of Bemarituzumab at 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
finance.yahoo.com - January 17 at 6:50 PM
Five Prime Therapeutics Announces Two Poster Presentations at the 2019 Gastrointestinal Cancers Symposium - Business WireFive Prime Therapeutics Announces Two Poster Presentations at the 2019 Gastrointestinal Cancers Symposium - Business Wire
www.businesswire.com - January 16 at 8:49 AM
Five Prime to cut 41 jobs in restructuringFive Prime to cut 41 jobs in restructuring
seekingalpha.com - January 15 at 5:48 PM
Five Prime Announces Restructuring to Focus on Clinical Development and Later-Stage Research PrioritiesFive Prime Announces Restructuring to Focus on Clinical Development and Later-Stage Research Priorities
finance.yahoo.com - January 15 at 5:48 PM
Five Prime Therapeutics Announces Two Poster Presentations at the 2019 Gastrointestinal Cancers SymposiumFive Prime Therapeutics Announces Two Poster Presentations at the 2019 Gastrointestinal Cancers Symposium
finance.yahoo.com - January 15 at 8:45 AM
Five Prime Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare ConferenceFive Prime Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 13 at 10:17 AM
Five Prime Therapeutics Announces Changes to its Board of DirectorsFive Prime Therapeutics Announces Changes to its Board of Directors
finance.yahoo.com - November 29 at 5:18 PM
Five Prime Therapeutics to Present at 30th Annual Piper Jaffray Healthcare ConferenceFive Prime Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 20 at 5:01 PM
Five Prime Therapeutics Initiates Patient Dosing in a Phase 1 Clinical Trial of FPT155, a First-in-Class CD80 Fusion ...Five Prime Therapeutics Initiates Patient Dosing in a Phase 1 Clinical Trial of FPT155, a First-in-Class CD80 Fusion ...
www.businesswire.com - November 14 at 5:01 PM
Five Prime Therapeutics Initiates Patient Dosing in a Phase 1 Clinical Trial of FPT155, a First-in-Class CD80 Fusion ProteinFive Prime Therapeutics Initiates Patient Dosing in a Phase 1 Clinical Trial of FPT155, a First-in-Class CD80 Fusion Protein
finance.yahoo.com - November 14 at 5:01 PM
Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q3 2018 Results - Earnings Call TranscriptFive Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 8:50 AM
Five Prime Therapeutics: 3Q Earnings SnapshotFive Prime Therapeutics: 3Q Earnings Snapshot
finance.yahoo.com - November 7 at 8:50 AM
Five Prime Therapeutics (FPRX) Reports Q3 Loss, Misses Revenue EstimatesFive Prime Therapeutics (FPRX) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 7 at 8:50 AM
Edited Transcript of FPRX earnings conference call or presentation 6-Nov-18 9:30pm GMTEdited Transcript of FPRX earnings conference call or presentation 6-Nov-18 9:30pm GMT
finance.yahoo.com - November 7 at 8:50 AM
Five Prime Therapeutics Announces Third Quarter 2018 Financial ResultsFive Prime Therapeutics Announces Third Quarter 2018 Financial Results
finance.yahoo.com - November 6 at 5:07 PM
New finance chief at Five PrimeNew finance chief at Five Prime
seekingalpha.com - November 5 at 5:04 PM
Five Prime Therapeutics Announces David V. Smith Will Join asChief Financial OfficerFive Prime Therapeutics Announces David V. Smith Will Join asChief Financial Officer
www.marketwatch.com - November 5 at 5:04 PM
Five Prime Therapeutics announces David V. Smith as CFOFive Prime Therapeutics announces David V. Smith as CFO
seekingalpha.com - November 5 at 5:04 PM
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel